ZL-6201 for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate the safety and tolerability of investigational study drug ZL-6201 for treating sarcoma and solid tumors cancer.
Are You a Good Fit for This Trial?
Adults over 18 with certain types of advanced sarcoma or solid tumors can join this trial. They should be relatively healthy (ECOG status 0 or 1), have a life expectancy over three months, and have received limited prior treatments (no more than 3 for solid tumors, no more than 2 for sarcomas). Participants need measurable cancer lesions, good organ function, and must not have HIV/HBV/HCV. A biopsy is required before treatment starts.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive ZL-6201 as a single agent in 21-day cycles to evaluate safety, tolerability, and preliminary efficacy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ZL-6201
Trial Overview
The study tests ZL-6201's safety and how well it works in treating sarcoma and other solid tumor cancers. It's an early-phase trial to see how patients tolerate the drug and to observe any preliminary signs of its effectiveness against these cancers.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
ZL-6201 as a single agent
Find a Clinic Near You
Who Is Running the Clinical Trial?
Zai Lab (Shanghai) Co., Ltd.
Lead Sponsor
Zai Lab (US) LLC
Industry Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.